News

Scientists at the University of Maryland identify vtRNA2-1 as a therapeutic target for inflammatory bowel disease.

Scientists at MIT have developed a 3D microfluidic model of the neuromuscular junction, advancing research into neuromuscular diseases.

Strathclyde University scientists have developed a novel single-cell culture method to study cardiovascular disease-related changes in vascular smooth muscle cells

Researchers in Germany have discovered targeting EDI3 shows therapeutic promise for HER2-positive breast cancer.

Read about Kerstin Filippi and Miriana Dardano's experience at ISSCR 2023 in Boston after receiving AMSBIO's $1,000 Travel Grant

With the support of AMSBIO, students from the Technical University of Munich (TUM) have sent neuronal cells to space to study Alzheimer's disease.

Scientists at the University of Tokyo and Yokohama City University have developed an animal-derived product free protocol for mass production of mini-livers.

Researchers at the University of Exeter have identified an miRNA which attenuates the functional and behavioural effects of stress in mice, with custom lentiviral particles from AMSBIO.

Scientists at Newcastle University Centre for Cancer have identified a novel diagnostic biomarker and potential therapeutic target for prostate cancer.

An interview with Dr Hynda Kleinman and Dr Meri Huch in honour of International Women's Day and World Organoid Research Day

Scientists at Harvard Medical School have successfully created a kidney organoid with vascular structure using StemFit medium.

Scientists have established a protocol to recapitulate human germ cell development in vitro using iPSCs.

Researchers at the University of Leeds are using our reagents for the production, visualization, and analysis of glycans and investigating their interactions.

Researchers at Institut de Biologie Structurale investigate heparan sulfate structure and function using CELLBANKER 2 as a cryopreservation medium, and AMSBIO 10E4 antibody for detection.

Scientists at Stanford University used iPSCs to develop a potential cure for the rare genetic skin disease, Epidermolysis Bullosa

Dr. Erik Miljan explains the importance of being GMP Ready with an established & secure GMP supply chain for a streamlined clinical translation.

Scientists at the UMass Chan Medical School developed a two-step protocol for isolating and growing 'induced myoblasts' from induced pluripotent stem cells

Scientists, University of Oulu (Finland), have identified novel miRNAs that regulate development of myocardial fibrosis and could serve as potential targets of therapy for myocardial fibrosis.

Researchers at Keio University, transplant the first human iPS cell-derived neuronal progenitor cells for spinal cord injury. Find out how.

Obesity is associated with Heparan sulfates that regulate mitochondria transfer to macrophages. Find out how.

“AMSBIO prize-winning poster” in the UK Proteoglycans 2022 for promising early-stage researchers as part of our involvement with this exciting area of science.

AMSBIO have made a new strategic investment to enhance the level of support to its sizeable and growing base of customers across the European Union.

A group of scientists at the Medical University of Vienna, have recently designed, fabricated, and tested a microfluidic chip system capable of reliably generating many spheroids of defined sizes

Scientists at BMLS in Frankfurt have used AMSBIOs custom lentivectors to visualize cell nuclei and F-actin cytoskeleton in their organoids

Discover how Dr. Takayama (CiRA, Kyoto University) successfully modelled the SARS-CoV-2 life cycle in undifferentiated iPSCs.

Scientists at the centre for Stem Cell Biology at the MSKCC (USA) have developed a pioneering Cell Therapy treatment for Parkinson’s Disease

Learn how scientists at the University of Glasgow used eGFP-expressing lentiviral particles to track and measure re-myelination.

An interview with Assoc. Prof. Taro Takami from Yamaguchi University discussing his liver regeneration research